Keywords: ex-us, drug, sales, boost, 1st-qtr, earnings, despite
Ex-US drug sales boost J&J's 1st-qtr 2008 earnings 40%, despite generic competition
Article | 21 April 2008
Johnson & Johnson's first-quarter 2008 results beat expectations as the US health care major saw strong sales of consumer products and a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
